Code | 1843E | ||||||||||
MA number | 15/0137/24-S | ||||||||||
Product Form: | plc ifc 1x500 mg (liek.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Olikla s.r.o., Czechia | ||||||||||
Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 06.06.2024 |
Validity: | 06.06.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Vancomycin Olikla 500 mg a 1000 mg_06_2024.pdf |
SPC: | SPC_Vancomycin Olikla 500 mg a 1000 mg_06_2024.pdf |
Safety feature | Yes |
Data update: | 10.06.2024 |